Norway· NO-ID_1F40FD24-4DB1-406D-AEE5-92EA3AA94AF3

Wakix

A pitolisant product containing pitolisant, registered in Norway by Bioprojet Pharma. The same ATC class is registered in 15 of our 19 countries.

ATC N07XX11

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedWakixATCN07XX11REGISTER NO.NO-ID_1F40FD24-4DB1-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Pitolisant is registered in 15 of 19 countries.

Countries holding a registration under ATC N07XX11 (pitolisant), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 10 of them publish a price we can compare per daily dose

Pitolisant · ATC N07XX11

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pitolisant costs, country by country.

Normalised to the WHO defined daily dose (18 mg), the median price runs from $21.04 in France to $43.24 in Italy — a ×2.1 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Pitolisant · price per daily dose (18 mg)

USD · FX 28 Sept 2026

  • IT Italy$43.24
  • FR France$21.04
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Pitolisant
Manufacturer
Bioprojet Pharma
Country
Norway (NO)
ATC code
N07XX11
ATC class
Pitolisant
Defined daily dose
18 mg, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

1 priced
  • no_merkevare_id
    ID_1F40FD24-4DB1-406D-AEE5-92EA3AA94AF3
  • no_varenummer
    596229
    30
    NOK 4188.1
  • gtin
    3760254600162

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

272 interactions on record for pitolisant.

Graded by severity as the source publishes them — 49 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Pitolisant · interactions on record

272 records

  • 49 severe
  • 221 moderate
  • 2 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • PapaverinC04AX38severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pitolisant in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pitolisant products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Iceland · Ozawade, Wakix
  • Liechtenstein · Ozawade, Wakix

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d8ee9b99-8f94-44af-9f6c-de397d2d4776
GET /v1/drugs/d8ee9b99-8f94-44af-9f6c-de397d2d4776?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett, filmdrasjert",
  "source": "fest",
  "status": "A",
  "atc_name": "Pitolisant",
  "merkevare_id": "ID_1F40FD24-4DB1-406D-AEE5-92EA3AA94AF3",
  "name_form_strength": "Wakix tab 4,5 mg",
  "prescription_group": "C"
}

See everything about pitolisant.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.